Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing 1 - 25 of 840
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

Recruiting
  • Myelodysplastic Syndromes
  • Blood test
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Nov 27, 2023

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

Recruiting
  • Myelodysplastic Syndromes
  • Unrelated Umbilical Cord Blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

Recruiting
  • Myelodysplastic Syndromes
  • IV Decitabine
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Based on Quantitative Pharmacology in Patients With Lenalidomide

Recruiting
  • Multiple Myeloma
  • +2 more
    • Jinan, Shandong, China
      the First Affiliated Hospital of Shandong First Medical Universi
    Oct 3, 2023

    Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Sep 18, 2023

    AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

    Not yet recruiting
    • AML
    • +5 more
    • Infusion of CD34 selected hematopoietic stem cells
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 14, 2023

    Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Sep 18, 2023

    MDS Trial in Worldwide (Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Los Alamitos, California
    • +53 more
    Sep 13, 2023

    MDS Trial (Roxadustat in combination with retinoic acid)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Roxadustat in combination with retinoic acid
    • (no location specified)
    Aug 26, 2023

    Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

    Not yet recruiting
    • Leukemia
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 28, 2023

    Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • TQB2928 Injection + Azacitidine for injection
    • Beijing, Beijing, China
    • +8 more
    Aug 22, 2023

    MDS Trial in Beijing (Roxadustat, Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 17, 2023

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +10 more
    • Jacksonville, Florida
    • +5 more
    Aug 14, 2023

    Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Fludarabine, busulfan and melphalan
    • Fludarabine and Busulfan
    • Fuzhou, Fujian, China
    • +8 more
    Aug 14, 2023

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    Stem Cell Transplantation, MDS, Leukemia, Myeloid, Acute Trial in Miami (Mindfulness-based Music Therapy (MBMT), Mindfulness

    Not yet recruiting
    • Stem Cell Transplantation
    • +4 more
    • Mindfulness-based Music Therapy (MBMT)
    • Mindfulness Meditation (MM)
    • Miami, Florida
      University of Miami
    Aug 1, 2023

    Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

    Not yet recruiting
    • Immune System Diseases
    • +15 more
    • observational cohort study
    • (no location specified)
    Jul 23, 2023

    MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Jul 30, 2023

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023